Researchers describe tools to better understand CaMKII, a protein involved in brain and heart disease

The health impacts of a complex protein that plays a major role in the development of Alzheimer's disease and heart conditions can be lessened by three kinds of drug inhibitors, according to scientists at the University of Colorado Anschutz Medical Campus. The protein, CaMKII, is ubiquitous in cells throughout the body but is perhaps best known for its prominent role in the brain and the heart. It is critical in learning and memory but if misregulated can cause problems.

"The most powerful engine to drive new discoveries on CaMKII functions may lie in the availability of three distinct classes of pharmacological inhibitors," said the manuscript's senior author Ulli Bayer, PhD, professor of pharmacology at the University of Colorado School of Medicine. "These inhibitors now allow a detailed first assessment of CaMKII functions in any given system in a way that is readily accessible to a broad range of scientists without specialized interest in CaMKII research." The drugs now allow a detailed first assessment of CaMKII functions in any given system that's accessible to a wide range of scientists

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Researchers identify gene involved in neuronal vulnerability in Alzheimer's diseaseEarly stages of neurodegenerative disorders are characterized by the accumulation of proteins in discrete populations of brain cells and degeneration of these cells. For most diseases, this selective vulnerability pattern is unexplained, yet it could yield major insight into pathological mechanisms.
Source: ScienceDaily - 🏆 452. / 53 Read more »

Research suggests a high-fat diet may slow the progression of Alzheimer's.Researchers are investigating the keto diet as a treatment for Alzheimer’s disease.
Source: PsychToday - 🏆 714. / 51 Read more »

Earliest-yet Alzheimer's biomarker found in mouse model could point to new targetsA surge of a neural-specific protein in the brain is the earliest-yet biomarker for Alzheimer's disease, report researchers studying a mouse model of the disease.
Source: ScienceDaily - 🏆 452. / 53 Read more »